A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin

Keum Yong Seong, Min Soo Seo, Dae Youn Hwang, Eoin D. O'Cearbhaill, Seamus Sreenan, Jeffrey M. Karp, Seung Yun Yang

Research output: Contribution to journalArticlepeer-review

141 Scopus citations

Abstract

Proteins are important biologic therapeutics used for the treatment of various diseases. However, owing to low bioavailability and poor skin permeability, transdermal delivery of protein therapeutics poses a significant challenge. Here, we present a new approach for transdermal protein delivery using bullet-shaped double-layered microneedle (MN) arrays with water-swellable tips. This design enabled the MNs to mechanically interlock with soft tissues by selective distal swelling after skin insertion. Additionally, prolonged release of loaded proteins by passive diffusion through the swollen tips was obtained. The bullet-shaped MNs provided an optimal geometry for mechanical interlocking, thereby achieving significant adhesion strength (~ 1.6 N cm− 2) with rat skin. By harnessing the MN's reversible swelling/deswelling property, insulin, a model protein drug, was loaded in the swellable tips using a mild drop/dry procedure. The insulin-loaded MN patch released 60% of insulin when immersed in saline over the course of 12 h and approximately 70% of the released insulin appeared to have preserved structural integrity. An in vivo pilot study showed a prolonged release of insulin from swellable MN patches, leading to a gradual decrease in blood glucose levels. This self-adherent transdermal MN platform can be applied to a variety of protein drugs requiring sustained release kinetics.

Original languageEnglish
Pages (from-to)48-56
Number of pages9
JournalJournal of Controlled Release
Volume265
DOIs
StatePublished - 10 Nov 2017

Keywords

  • Insulin delivery
  • Mechanical interlocking
  • Microneedle
  • Transdermal patch

Fingerprint

Dive into the research topics of 'A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin'. Together they form a unique fingerprint.

Cite this